hcrn gu16-260: nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with adv...
Published 4 years ago • 51 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
5:44
hcrn-gu16-260: nivolumab and salvage nivolumab-ipilimumab in patients with advanced rcc
-
5:52
nivolumab and salvage nivolumab plus ipilimumab for arcc
-
8:07
hcrn gu16-260: nivolumab, salvage nivo/ipi in advanced clear cell rcc
-
6:16
treatment-free survival results of nivolumab and salvage nivolumab ipilimumab for accrcc
-
8:26
front-line therapy with nivolumab and salvage nivolumab ipilimumab in patients with advanced rcc
-
5:19
fraction-rcc: evaluating nivolumab plus ipilimumab in patients with treatment-refractory advance...
-
6:00
clinical trial for advanced kidney cancer: hcrn gu16-260
-
9:09
nivolumab with alternatively scheduled ipilimumab in first-line treatment of advanced rcc
-
5:42
asco: nivolumab followed by salvage ipilimumab plus nivolumab for patients with advanced rcc
-
11:58
checkmate 214: nivolumab ipilimumab or sunitinib in patients with advanced renal cell carcinoma
-
3:23
nivolumab improves overall survival for advanced kidney cancer
-
4:50
ipilimumab/nivolumab in first-line mrcc
-
4:22
cabozantinib in combination w/ nivolumab and ipilimumab of imdc intermediate or poor risk signif...
-
1:55
investigating responses to nivolumab and ipilimumab in advanced rcc
-
7:03
ipilimumab/nivolumab for favorable-risk mrcc
-
1:33
dr. mcdermott on single-agent nivolumab in rcc
-
3:14
comment: nivolumab plus ipilimumab combination for advanced nsclc
-
4:39
nivolumab and ipilimumab for metastatic kidney cancer
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer